In the pig, transforming growth factor beta (TGFB), TGFB receptors (TGFBRs), and integrins are present during the periimplantation period. Latency-associated peptide (LAP), a part of latent TGFB, can bind to integrin heterodimers via its Arg-GlyAsp (RGD) sequence; therefore, ligand-receptor interactions between TGFB and TGFBRs, along with LAP and integrin heterodimers, may be functional in mediating events supporting conceptus elongation and attachment. With the use of surgically implantable osmotic pumps, we were able to maintain pregnancy with the aim of mechanistically altering in vivo receptorligand interactions involving TGFB with TGFBRs and LAP with integrins during porcine pregnancy. Day 9 pregnant gilts received intrauterine infusions of LAP-RGD, a recombinant mutant of LAP (LAP-RGE), or vehicle control and were ovariohysterectomized on Day 13 or 24 of pregnancy. We hypothesized that intrauterine infusion of LAP-RGD would decrease downstream signaling of TGFB while increasing LAPintegrin interactions and that net effect would enhance conceptus survival and attachment early in the peri-implantation period but possibly increase the chance of abnormal placentation later in pregnancy. Additionally, we hypothesized that infusion of LAP-RGE would disrupt TGFB signals but not alter integrin signaling, and thus the net result would be decreased conceptus survival and abnormal development. Unexpectedly, LAP-RGD intrauterine infusions resulted in a reduction of conceptus elongation, whereas infusions of LAP-RGE permitted implantation and placentation but resulted in larger fetal weight, allantois length, and allantoic fluid volume. Results suggest TGFB and integrins are contributing factors in the regulation of conceptus elongation and placental and fetal size.
INTRODUCTION
Mechanisms supporting conceptus elongation and attachment during porcine pregnancy remain largely unknown.
During this critical period, cross-talk between the conceptus and uterus mediates conceptus development and implantation, and asynchrony in this communication results in conceptus mortality [1] [2] [3] . Implantation in pigs is superficial, and prior to attachment, conceptuses transform from spherical (5 mm) to filamentous (150 mm) forms between Days 10 and 12 of pregnancy [4] . In a receptive uterine environment, filamentous conceptuses begin to make initial attachments to the uterine luminal epithelium (LE) by Day 13 of pregnancy, and porcine implantation is essentially complete by Day 24 of pregnancy, resulting in interdigitation of LE and the trophectoderm [5] .
Experimental intrauterine infusions through the use of implantable osmotic pumps have been used to study the development of the conceptus, physiology of the uterus, pathogenesis of reproductive infections, and, to a limited extent, to deliver substances to uteri of domestic livestock [6] [7] [8] . Such experimental infusions have been previously used in pigs, but not to investigate conceptus development and attachment during the peri-implantation period [9] [10] [11] . The establishment of a delivery system that remains contained within the abdominal cavity, enables controlled delivery of substances to the uterine lumen of pregnant gilts, and does not disrupt pregnancy, would be a significant advance in allowing for alteration of in utero levels of proteins and molecules proposed to be involved in mediating porcine conceptus development and attachment.
Transforming growth factor beta (TGFB), TGFB receptors (TGFBRs), and integrins may contribute to the events of porcine implantation [12] [13] [14] [15] [16] . TGFB homodimers are secreted by the cell in latent complexes, which include its prepropeptide latency-associated peptides (LAP), with which the homodimers are noncovalently associated. These complexes further associate with latent TGFB binding proteins (LTBPs), which can sequester the inactive growth factor to the extracellular matrix (ECM) [17] [18] [19] . Activation of latent TGFB must occur prior to TGFB signaling through TGFBRs. Activation of TGFBRs results in phosphorylation of downstream effector SMAD proteins 2 and 3 (p-SMAD2/3) and subsequent translocation of the phosphorylated SMADs into the nucleus with SMAD4. The combination of SMADs and cofactors included in the transcriptional complex regulates the transcriptional activity of target genes [20] [21] [22] .
Extracellular activation of TGFB results from conformational changes in the latent complex or dissociation of TGFB from LAP [23] [24] [25] . In addition to conferring latency to TGFB, the LAPs that associate with TGFBs 1 and 3 contain Arg-GlyAsp (RGD) sequences that are recognized and bound by specific integrins [26] . Integrins are a family of transmembrane glycoprotein receptors that form noncovalent alpha and beta heterodimers, bind to multiple ECM proteins, aggregate, and form focal adhesions to stabilize cell attachments and serve as signaling centers [27] [28] [29] [30] . LAP via its RGD sequence can bind to integrin heterodimers on cell surfaces [31] [32] [33] [34] , and these interactions, along with TGFB and TGFBR interactions, may function in supporting events of the peri-implantation period.
Receptor-ligand interactions involving TGFB with TGFBRs and LAP with integrins during porcine pregnancy have yet to be mechanistically altered in vivo. We hypothesized that altering such interactions would affect conceptus development and attachment. Conduct of such investigations would require a specialized means for in vivo intrauterine infusion of exogenous proteins that is also compatible with maintenance of pregnancy. Therefore, we developed a system for repeated delivery of exogenous LAP at physiological concentrations directly into the uterus of pregnant gilts, which would require minimal postsurgery manipulation and restraint. Use of this novel delivery system to infuse LAP containing its native RGD site (LAP-RGD) and a recombinant mutant of LAP (LAP-RGE) into the uterine lumen of pregnant gilts offers the potential to aid in our understanding of TGFB-and LAPintegrin-mediated effects on conceptus development and attachment. LAP decreases in vitro TGFB activity by recombining with active TGFBs, rendering them latent, and thus inhibiting TGFB from binding to TGFBRs. Further in vitro evidence supports that LAP-RGD, but not LAP-RGE, can bind to integrin receptors and support cell adhesion [35] . Exogenous LAP-RGD infused into the uterine lumen of pregnant gilts beginning on Day 9 of pregnancy is thus expected to disrupt the balance of active TGFB and alter normal integrin signaling during the peri-implantation period, whereas exogenous LAP-RGE infusions will disrupt TGFB activity without altering integrin-ligand interactions at the conceptus-maternal interface.
We hypothesized that intrauterine infusion of LAP-RGD during the peri-implantation period would decrease downstream signaling of TGFB at the conceptus-maternal interface while also increasing LAP-integrin interactions, and that the net effect would be enhanced conceptus survival and attachment early in the peri-implantation phase but possibly abnormal placentation later in pregnancy. In contrast, infusion of LAP-RGE would be expected to disrupt TGFB signals but, because of the RGD to RGE mutation, would not alter integrin signaling, and thus the net result would be decreased conceptus survival and abnormal development. This design would thus aid in distinguishing between TGFB-and integrin-mediated effects on conceptus development and attachment.
MATERIALS AND METHODS

Animals and Tissue Collection
All experimental and surgical procedures complied with the Guide for Care and Use of Laboratory Animals and were approved by the Texas A&M University Laboratory Animal Care and Use Committee. Gilts were observed daily for estrus (Day 0) and mated with boars at 12 and 24 h after the onset of estrus. Study 1. In order to verify that we could deliver low concentrations of proteins to the pregnant uterus during the peri-implantation period without apparent adverse effects on the endometrial mucosa, conceptus development, or conceptus attachment, three gilts underwent bilateral catheterization of uterine horns and received infusions of 0.1% porcine serum albumin (PSA) from Days 9 through 13 of pregnancy. An additional three gilts underwent an initial surgery on Day 9 of pregnancy and were ovariohysterectomized on Day 24 of pregnancy.
Anesthesia was induced in gilts on Day 9 of pregnancy by intramuscular injection of tiletamine hydrochloride and zolazepam hydrochloride (6.6 mg/kg) and was maintained with isoflurane (2%-4% in oxygen). Sterile ALZET osmotic pumps (Durect Corp., Cupertino, CA), previously prepared as per manufacturer's instructions, were installed into each uterine horn. To install the pumps, the polyethylene catheter (1.2-mm outside diameter) was inserted into the transected end of the uterine tube and threaded toward the uterine horn until 1-2 cm of the catheter resided in the uterine horn. Two encircling ligatures of 2-0 polygalactin 910 were placed around the uterine tube containing the polyethylene catheter. After the catheter was secured in the uterine tube, the pump was slipped into the ovarian bursa, and the mesovarium was sutured closed, using 2-0 polygalactin 910. Two additional encircling sutures were placed through the mesovarium, around the pump, to ensure that the pump remained in the bursa adjacent to the ovary (Fig. 1, A and B) .
Ovariohysterectomies were performed on Days 13 and 24 of pregnancy. Immediately after their removal, reproductive tissues were visually assessed to assure placement and patency of catheters and document the conditions of the ovaries and any gross abnormalities of the reproductive tract. In addition, any remaining fluid was aspirated from the removed pumps and measured to assure that pumps had delivered the expected volume of fluid over the experimental period. On Day 13 of pregnancy, 50 ml of 10 mM Tris was used to flush conceptuses from each horn separately. On Day 24 of pregnancy, uterine horns were not flushed but rather opened longitudinally along the antimesometrial border. The presence and gross normality of fetuses was visually assessed. Day 13 conceptuses and full-thickness uterine tissue samples from Days 13 and 24 of pregnancy were fixed in 4% paraformaldehyde (4% PAF) prepared in PBS (pH 7.2). Routine processing of uterine and conceptus tissues into paraffin followed. Sections were processed and stained with hematoxylin and eosin (H&E) and evaluated by a board-certified pathologist (B.R.W.) for any histopathological abnormalities.
Study 2. Surgical implantation of two indwelling osmotic pumps was performed on Day 9 of pregnancy, as described in study 1. Pumps delivered either LAP-RGD or LAP-RGE (9.6 lg LAP-RGD or LAP-RGE per horn per day delivered in PSA vehicle for a total protein concentration of 1 mg/ml; n ¼ 5 gilts per treatment group) or PSA into each uterine horn at a rate of 10 ul/h. On Day 13 of pregnancy, ovariohysterectomies were performed, and assessment of placement and patency of catheters was noted, as described in study 1. Conceptuses from each uterine horn were flushed with 10 mM Tris HCl on Day 9 of pregnancy, and both uterine and conceptus tissues were preserved as described in study 1.
Treatments that resulted in grossly normal conceptus development and maintenance of pregnancy on Day 13 were used for an additional experiment using another group of gilts, beginning on Day 9 of pregnancy and concluding at the completion of implantation on Day 24 of pregnancy. Day 9 pregnant gilts underwent surgical implantation of two indwelling osmotic pumps as described above; pumps delivered either LAP-RGE or PSA control (9.6 lg LAP-RGE per horn per day delivered in PSA vehicle for a total protein concentration of 1 mg/ ml; n ¼ 5 gilts per treatment group) for approximately 7.5 days, until the 2-ml volume within the pump was expended. At ovariohysterectomy on Day 24 of pregnancy, uterine horns were opened along the antimesometrial border, and placental and fetal parameters, including allantois length (cm), allantoic fluid volume (ml), fetal length (crown to rump, cm), fetal weights (g), and number of fetuses per litter, were recorded. Placental attachment sites and fetuses were preserved in 4% PAF as described, and placental attachment sites were routinely processed, embedded in paraffin, sectioned, stained with H&E, and evaluated histopathologically as described above.
Immunohistochemistry
Commercially available rabbit anti-phosphorylated SMAD2/3 (p-SMAD2/ 3) (Santa Cruz Biotechnology, Santa Cruz, CA) was used for immunohistochemical staining. Uterine and conceptus paraffin-embedded tissues were sectioned (5 lM) and mounted on Superfrost plus slides. Tissues were deparaffinized with xylene and rehydrated through a graded series of alcohol. Endogenous peroxidase was blocked with 0.3% H 2 O 2 in dH 2 O. As suggested by the manufacturer, sections were subjected to antigen retrieval with citrate buffer (pH 6.2) at 808C for 45 min. Sections were blocked with 10% normal goat serum at 258C for 20 min and incubated overnight at 48C with primary antibody p-SMAD 2/3 (0.4 lg/ml) or control rabbit IgG (0.4 lg/ml) in 2% bovine serum albumin (BSA) in PBS (PBSA). Sections were rinsed with PBSA and PBSA containing 1% Triton, then incubated with biotin-conjugated secondary antibody diluted in PBSA containing 5% normal goat serum for 1 h at 258C. Sections were rinsed as described, incubated in Vectastain ABC (Vector Laboratories, Burlingame, CA) for 30 min at room temperature, and rinsed again with PBS and 0.5 M Tris-HCl. Immunoreactions were detected with peroxidase solution (DAB/H 2 O 2 ) and stopped by submerging in H 2 O at 1.5 min after application of peroxidase solution. Sections were counterstained with Shandon Eosin-y aqueous (Thermo Scientific, Waltham, MA), rinsed with distilled water, dehydrated with the reverse series of graded alcohol, and coverslipped with Clarion Mounting Medium (Biomeda Corp., Foster City, CA). Sections were evaluated by two independent investigators who were blinded to sample identity and treatment. Intensity of p-SMAD2/3 immunostaining for trophectoderm, uterine LE, and glandular (GE) was graded as (-) no LAP AFFECTS CONCEPTUS ELONGATION AND PLACENTA SIZE 535 immunostaining, (þ) weak and/or intermittent immunostaining, (þþ) moderate immunostaining, or (þþþ) strong immunostaining.
Statistical Analysis
Quantitative data from Day 24 infused gilts in study 2 were subjected to least-squares ANOVA using the General Linear Models procedures of the Statistical Analysis System (version 9.1; SAS Institute, Cary, NC). Tests of significance were performed using the appropriate error terms according to the expectation of the mean squares for error, and P , 0.05 was considered statistically significant.
Photomicrography
Digital photomicrographs of immunohistochemistry and H&E-stained sections were evaluated using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) interfaced with an Axioplan HR digital camera and Axiovision 4.3 software. Photographic templates were assembled using Adobe Photoshop (version 6.0; Adobe Systems Inc., San Jose, CA).
RESULTS
Effects of Surgical Implantation of Osmotic Pumps
At hysterectomy, uteri from Days 13 and 24 pregnant gilts exhibited normal muscular tone and visible exterior striations, as is commonly observed at this stage of pregnancy, and catheters and pumps remained in place (Fig. 1C) . In gilts receiving PSA treatment until Day 13 of pregnancy, conceptuses were recovered from both uterine horns. Some variability in developmental stage was observed between and within the recovered litters; however, all conceptuses were in elongated, filamentous forms (Fig. 2, A and B) . The mucosa of the endometrium, after opening the horns longitudinally, appeared grossly normal in all three gilts (Fig. 2C) . In gilts receiving PSA treatments until Day 24 of pregnancy, development of fetuses appeared to be grossly normal and implantation sites were maintained (Fig. 3, A and B) .
No significant histopathological abnormalities were noted in H&E-stained sections of Day 13 endometrial mucosae or conceptus tissue or Day 24 implantation sites. All endometrial sections were characterized by mild submucosal edema with occasional dilated lymphatics, mild margination of neutrophils within submucosal veins, and rare submucosal eosinophils.
Intrauterine Infusions of Recombinant LAP-RGD Reduce Conceptus Elongation on Day 13 of Gestation (Study 2)
In the LAP-RGD-infused gilts, reduction in conceptus elongation in both horns of four out of five litters was grossly visible (Fig. 4A) . In litter 1, spherical and filamentous conceptuses with bulbous ends were present, and two spherical conceptuses had sizes 0.5 cm and 0.65 cm. In litter 2, spherical and filamentous conceptuses were present, and five spherical conceptuses were size 0.15 cm, 0.5 cm, 0.9 cm, 1.0 cm, and 1.0 cm. In litter 3, conceptuses appeared to elongate; however, some filamentous conceptuses appeared to have lost their normal structure and presented as sheets of trophoblast. In litter 4, spherical and filamentous conceptuses with bulbous ends were present, and three spherical conceptuses were size 0.6 cm, 0.75 cm, and 0.8 cm. In litter 5, all conceptuses failed to elongate; conceptuses were characterized as five spherical and one tubular and and were size 0.3 cm, 0.4 cm, 0.5 cm, 0.7 cm, and 0.9 cm, and 1.5 cm, respectively.
In LAP-RGE-and PSA-infused gilts, overall morphology of conceptuses in both treatment groups was grossly normal (Fig. 4, B and C) . Nearly all conceptuses from all gilts in LAP-RGE-and PSA-treated groups were filamentous, and few filamentous conceptuses contained bulbous ends. Only one spherical conceptus was reported for each LAP-RGE-and PSA-infused litter, and their sizes were 0.8 cm and 1.0 cm, respectively.
p-SMAD 2/3 Immunohistochemistry (Study 2)
SMAD proteins 2 and 3 are phosphorylated in response to TGFB signaling through TGFBRs and are subsequently translocated to nuclei. Therefore, immunohistochemical analysis of nuclear p-SMAD2/3 was performed on Day 13 conceptus and endometrial tissues of each treatment group
FIG. 1. Surgical implantation of osmotic pumps.
A) The uterine tube was transected (arrow), and the polyethylene catheter was inserted and passed into the uterine horn. The mesosalpinx (arrowhead) was often transected to help relieve tortuosity of the uterine tube and ease passage of the catheter. B) Encircling ligatures were used to secure the polyethylene catheter within the uterine tube (arrow), and one to two drops of sterile cyanoacrylate glue were applied to the uterine tube, catheter, and suture. The pump was slipped into the ovarian bursa, and two encircling sutures (arrowhead) were placed through the mesovarium around the pump. C) Exteriorized uterus and ovaries just prior to ovariohysterectomy on Day 13 of gestation. Corpora lutea (arrowheads) are present on the ovaries. Pumps are enclosed within the ovarian bursa (arrows).
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(LAP-RGD, LAP-RGE, or PSA) as an approximation of TGFB activity within uterine and conceptus tissues. In all treatment groups, p-SMAD2/3 was detected in nuclei of the conceptus trophectoderm, endometrial LE, endometrial GE, fibroblast cells, and endothelial cells (Fig. 5) . Further, immunostaining for p-SMAD2/3 in the LAP-RGE treatment group appeared less intense in endometrial LE compared to immunostaining in LE of LAP-RGD-and PSA-treated groups and was graded a lower score in blinded evaluations (Table 1) .
Intrauterine Infusions of Recombinant LAP-RGE Affect Placental and Fetal Development by Day 25 of Gestation (Study 2)
Conceptus development was impaired by Day 13 of pregnancy when LAP-RGD was infused into the uterus; however, conceptuses from LAP-RGE-treated groups achieved elongation, and no disruption of pregnancy was apparent. Therefore, additional studies were employed to determine if infusing LAP-RGE resulted in long-term effects on conceptus attachment and/or fetal and placental development. Pregnant gilts were infused with LAP-RGE or PSA control beginning on Day 9 of pregnancy and were hysterectomized on Day 24. These infusions, which spanned from Day 9 to approximately Day 16 of pregnancy, were designed to determine the effects on implantation and conceptus development that would result from LAP-induced inhibition of TGFB activity that was not accompanied by concurrent alteration of integrin activity from the native RGD site present in LAP.
Sections (H&E) of placental attachment sites in LAP-RGE and PSA groups indicated that infusions of LAP-RGE resulted in no detectable histopathological abnormalities in attachment (Fig. 6 ). Fetal weight, fetal length, allantois length, allantoic fluid volume, and number of fetuses for LAP-RGE-and PSAtreated groups were recorded at ovariohysterectomy on Day 24 of pregnancy. The least square means and standard errors for the LAP-RGE-treated group were 0.47 6 0.04 g, 1.55 6 0.08 cm, 11.85 6 0.97 cm, 54.37 6 5.38 ml, and 8.60 6 0.71 fetuses per litter, respectively. Means and standard deviations for PSA control group were 0.29 6 0.04 g, 1.36 6 0.08 cm, 8.17 6 1.03 cm, 24.16 6 4.89 ml, and 8.20 6 0.71 fetuses per litter, respectively (Table 2 ). Compared to PSA infusions, LAP-RGE infusions resulted in a 62% increase in fetal weight, a 45% increase in allantois length, and a 125% increase in allantoic fluid volume. There was no significant difference in the number of fetuses between treatment groups; however, it was noted that five pairs of placentas in the LAP-RGE-treated group were in contact with one another. Furthermore, two of LAP AFFECTS CONCEPTUS ELONGATION AND PLACENTA SIZE these pairs were overlapping by greater than 50%, and an additional fetus was located in the uterine body. In contrast, in the control group, only two pairs of placentas were in contact with one another, and none of these exhibited overlapping to the degree seen in the LAP-RGE-treated group.
DISCUSSION
Results of these studies clearly demonstrate that substances can be infused in a continuous, controlled manner to the intrauterine lumen of pregnant gilts and further, that such infusion is compatible with maintenance of pregnancy through the peri-implantation period. Intrauterine infusions of LAP-RGD, but not LAP-RGE or PSA, beginning on Day 9 of pregnancy in gilts resulted in a reduction of conceptus elongation by Day 13 of gestation. Further, intrauterine infusions of LAP-RGE through Day 16 of pregnancy permitted implantation and placental and fetal development. Interestingly, infusing with LAP-RGE resulted in larger fetal weight, allantois length, and allantoic fluid volume at Day 25 of gestation compared to infusing with PSA.
The surgical techniques described in this report were successful in allowing continual infusions into the uterine lumen over the entire time period defined. Compared to alternative methods that use exteriorized catheters [36] [37] [38] [39] , the use of surgically implanted, commercially available osmotic pumps permits minimal manipulations and disruptions to the animal during the period of treatment, continual infusion of substances rather than multiple bolus treatments, and decreased risk of infection from environmental sources. The process of infusion did not result in any gross or histopathologically significant alterations of the endometrium and conceptus tissues or conceptus attachment sites by Day 24 of pregnancy. Mild submucosal edema, dilated lymphatics, mild margination of neutrophils, and submucosal eosinophils were observed in the endometrium from all uteri; such changes are consistent with procedural effects of surgery resulting from clamping, suturing, and/or handling and are not considered to be pathologically significant. Thus, it appears that the infusion technique reported in study 1 would be broadly applicable to a wide range of studies focused on endometrial function during pregnancy.
Conceptus loss can reach 18% during preimplantation, and during this time, conceptus extraembryonic tissues elongate from a 5-mm sphere to a 150-mm filamentous form at a rate of 30-40 mm/h between Days 10 and 12 of pregnancy [4, 40] . The elongated conceptus provides increased surface area for exchange of nutrients between the conceptus and uterus and is essential for successful implantation. Investigation of factors that mediate conceptus elongation is complicated by the failure of conceptuses to elongate in vitro [41] . We are the first to demonstrate in vivo inhibition of conceptus elongation via intrauterine infusions during early pregnancy in pigs. Infusions of LAP-RGD inhibited conceptus elongation, whereas similar infusions of LAP-RGE had no visible effect on conceptus elongation. LAP-RGD, but not LAP-RGE, supports binding to integrins, and intrauterine infusions of LAP-RGE did not affect conceptus elongation, implicating integrin-mediated effects in the observed inhibition of conceptus elongation. In studies involving mice, intrauterine injections of RGD containing peptides and neutralizing monoclonal antibodies against integrin subunits resulted in the reduction of implantation [42] . In addition, phenotypes in mice with ITGA4-, ITGA5-, ITGAV-, and ITGB1-null mutations resulted in failure of chorioallantois fusion, placental defects, and embryonic deaths [43] [44] [45] [46] [47] [48] . In recent studies, intracellular signaling pathways involving TGFB and integrins were identified during conceptus elongation, suggesting mechanisms for growth factor signaling and cytoskeletal rearrangement/cell motility during conceptus elongation [49] . These studies, along with our current study, provide evidence that integrins are critical during the periimplantation period. A potential mechanism for LAP-RGD inhibition of conceptus elongation is that infused LAP-RGD inappropriately binds a significant number of integrins, thus preventing other integrin-ligand interactions or, alternatively, LAP AFFECTS CONCEPTUS ELONGATION AND PLACENTA SIZE 539 inappropriately stimulates ITGAV-containing heterodimers, thus causing interruptions in intracellular signaling cascades and linking the actin cytoskeleton that may be critical in initiating conceptus elongation. It is noted that in the LAP-RGD-treated group, some conceptuses achieved elongation. Osmotic pumps installed on Day 9 of pregnancy slowly delivered infusate at a rate of 10 ll/h, which may have been optimal for maintaining physiological concentrations; however, the infusate may not have reached the entire length of the uterine horn in time to completely disrupt receptor-ligand interactions. As a result, the conceptuses that achieved morphological elongation may not have been exposed to exogenous LAP-RGD within a critical period that, based on morphology of conceptuses, appears to encompass Day 10 of pregnancy. Porcine implantation is noninvasive; therefore, there is a need for a large surface area between placental and endometrial tissue for exchange of nutrients to support the growing fetus. Placental efficiency is measured by fetal weight-to-placental weight ratio, and large placental sizes are implicated as lower placental efficiency and as a limiting factor to litter size [50, 51] . Novel experiments by Wilson and Ford have demonstrated that administration of estradiol-17b around the time of conceptus elongation results in increased placental size at term. Increases in estradiol-17b may affect endometrial secretions of growth factors, which may ultimately affect placental size [52] . In support of this, our studies have demonstrated that infusing exogenous LAP-RGE during the time of conceptus elongation and early conceptus attachment results in increased fetal weight, allantois length, and allantoic fluid volume; however, litter size and fetal length were not affected. It is of particular interest that a portion of the placentas in the LAP-RGE-treated gilts were in contact with one another, potentially due to the large size of their allantoic membranes and/or abnormalities in embryo spacing. If pregnancy had been allowed to proceed, it seems quite possible that the overlapping placentas would have led to the death of the affected fetus and would have resulted in fewer fetuses in the RGE treatment group. Interestingly, in previous studies, insemination of gilts with TGFB1 resulted in lower placental weights and, therefore, greater placental efficiency, but had no effect on fetus number [53] . The apparent decrease in SMAD signaling in the uterine LE of LAP-RGE-infused gilts in our studies suggests that critical TGFB-regulated processes involving SMAD signaling may indirectly affect placental and fetal size. TGFB participates in regulating cellular growth, apoptosis, differentiation, and gene expression in many cell types, including epithelial, endothelial, and mesenchymal cells [54] . Therefore, we hypothesize that alterations in TGFB-induced SMAD signalling that regulates cellular behavior and/or 
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expression of maternal genes that are potentially involved in regulating components of fetal nutrition (i.e., histotroph and hematroph) during early porcine pregnancy result in larger placental and fetal size. The lack of SMAD inhibition by LAP-RGD infusions is not known; it is possible that the infused LAP-RGD, after binding endogenous TGFBs, underwent integrin-or enzyme-mediated activation at the luminal surface [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] . Likewise, we suspect that rapid turnover and activation of TGFB at the surface of the trophectoderm precluded any detectable change in TGFB activity by our experimental treatments.
In summary, we have developed a successful technique for immobilizing osmotic pumps in the porcine reproductive tract and delivering substances into the luminal cavity of the uterus. This methodology should prove useful for studies of uterine physiology and pathophysiology during early conceptus development that are relevant to pigs and other mammals. By use of these novel techniques, we demonstrate that infusing LAP-RGD beginning on Day 9 of porcine pregnancy reduces conceptus elongation, suggesting that appropriate integrinligand interactions are necessary for successful conceptus elongation during porcine pregnancy. In addition, infusing LAP-RGE on Days 9 through 16 of porcine pregnancy results in larger fetal weight, allantoic length, and allantoic fluid volume compared to infusing with PSA. The phenotype seen at Day 24 of pregnancy may be a result of altering TGFB-induced SMAD signaling in uterine epithelial cells during the critical time of conceptus elongation and implantation, ultimately affecting placental and fetal size. Although the precise mechanisms are not known at this time, current results implicate TGFB and integrins as contributing factors in the regulation of conceptus elongation and placental and fetal size.
